ArticleResearch (Washington, D.C.)2025
PRTS: Predicting Single-Cell Spatial Transcriptomic Maps from Histological Images.
Article in Research (Washington, D.C.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Spatiotemporal Deep Video-Phenomapping Decodes Microvascular Rarefaction in Middle-Aged and Elder Renovascular Hypertension: A Multi-Modal Study Integrating Spatial Transcriptomics and Mitochondrial Pyroptosis.Research (Washington, D.C.) · 2026Article
- Epigenetic Inflammation Supports Tumorigenesis: Activator Protein 1 Drives Stem Cell Memory to Augment Colitis and Cancer.Research (Washington, D.C.) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
21 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
High-resolution spatial transcriptomics (ST) data provide valuable insights into the molecular dynamics underlying complex biological processes. However, their widespread application remains limited due to high costs and technical challenges. Here, we present PRTS (Pathology-driven Reconstruction of Transcriptomic States), a novel framework that predicts single-cell-resolution ST data directly from histological images. Our results demonstrated that PRTS generated transcriptomic profiles for about 60,000 analyzable cell tiles per tissue section, representing an approximately 27-fold increase in analytical units compared to conventional ST spots and remarkably enhancing spatial resolution. Notably, PRTS achieves accurate cell-level transcriptomic predictions using only hematoxylin-and-eosin-stained tissue images. This method transforms costly ST technologies into a practical and scalable tool, offering a cost-efficient solution for comprehensive ST profiling in hematoxylin-and-eosin-based disease research.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.